Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Sickle Cell Anemia, Priapism

In brief

This research is being done to compare the effect of tadalafil with placebo (an inactive substance that looks like the study drug, but should have no effect) on the frequency of recurrent priapism (prolonged erection, unassociated with sexual interest or desire) and the nature of sexual experiences in male patients with sickle cell disease.

Key facts

Study ID
NCT00538564
Run by
Johns Hopkins University
People needed
0
Starts
2006-11-01
Expected to finish
2009-08-01
Last updated by the study team
2016-09-21

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.